ArticleJournal of experimental & clinical cancer research : CR2025

Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.

Bixing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.